Down-Regulation of Angiogenic Inhibitors: A Potential Pathogenic Mechanism for Diabetic Complications

Publisher： Bentham Science Publishers

E-ISSN： 1875-6417|1|2|183-196

ISSN： 1573-3998

Source： Current Diabetes Reviews, Vol.1, Iss.2, 2005-06, pp. : 183-196

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiogenic Growth Factors and their Inhibitors in Diabetic Retinopathy

By  

Current Diabetes Reviews, Vol. 6, Iss. 5, 2010-09 ,pp. : 304-312

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Role of Rho Kinase Inhibitors in Combating Diabetes-Related Complications Including Diabetic Neuropathy-A Review

By  

Current Diabetes Reviews, Vol. 9, Iss. 3, 2013-05 ,pp. : 249-266

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-angiogenic potential of small molecular inhibitors of cyclin dependent kinases in vitro

By Zahler Stefan  

Angiogenesis, Vol. 13, Iss. 3, 2010-09 ,pp. : 239-249

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Potential of Aldose Reductase Inhibitors in Diabetic Neuropathy

By Hamada Yoji   Nakamura Jiro  

Treatments in Endocrinology, Vol. 3, Iss. 4, 2004-01 ,pp. : 245-255

Adis International

Access to resources Recommend Favorite

The Potential Role of Thiamine (Vitamin B1) in Diabetic Complications

By  

Current Diabetes Reviews, Vol. 1, Iss. 3, 2005-11 ,pp. : 287-298

Bentham Science Publishers

Access to resources Recommend Favorite